Therefore, the C-terminal domain (183–394 and 280–394 aa fragments) of p42 is sufficient for the tumor suppressor activity of p42 in some breast cancer cells and glioma cells and these fragments appear to exert inhibitory effects by promoting p85 degradation through interaction with HSP70 and CHIP. This evidence concerns the gene STUB1 and breast carcinoma.